Navigation Links
Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
Date:4/18/2008

s are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company's ability to develop and introduce new products, differences in anticipated and actual product and service introduction dates, the ultimate success of those products in the marketplace, the continued acceptance and growth of current products and services, the impact of competitive products and services, the availability of sufficient quantities of suitable donated tissue and the success of cost control and margin improvement efforts. Certain of these factors are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. All information in this press release is as of April 18, 2008 and the Company does not intend to update this information.


'/>"/>
SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
2. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
3. Osteotech to Present at the Sidoti Conference in New York
4. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
7. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
8. Osteotech to Present at Sidoti Conference in San Francisco
9. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
10. Biomaxx Systems Inc. Renews Membership With Bioenergy Australia
11. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...irstCall/ -- ,, 3Q09 Corporate Highlights: ...keting Authorization to Astellas Pharma Europe Ltd...ess activities Expanded management team to includ...or, Commercial Operations Appointed Bradford S. G...airman , Upcoming 2009 Milestones: ,, ...
(Date:11/6/2009)... Intarcia Therapeutics, Inc. delivered two present...us delivery of exenatide) program for the treatmen...Technology Meeting in San Francisco, CA: ,, (Lo...SFTU126LOGO ) ,, Continuous Subcutaneous Deli...se, HbA1c and Reduces Weight in a 28-day Phase 1b ...
(Date:11/5/2009)...irstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today a...er ended September 30, 2009. GenVec reported a net...ree months ended September 30, 2009 compared to a ...comparable quarter of 2008. For the nine months en...1 million ($0.15 per share), compared to a net los...
(Date:11/5/2009).../ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX), ...d CEO of Imagenetix, will be presenting the Compan... Thursday, December 3rd, at 10:30 AM PST at the Lu..., LD MICRO is a by-invitation only newsletter fir... the micro-cap space. Since 2002, the firm has pub...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...AMSTERDAM, The Netherlands, August 5 ,Amsterdam Mo...the field of,human gene therapy, today announced t...first half year of 2008 on Wednesday, August 13, 2...s these results, the company,will conduct a confer...800-949-4517 (toll free); US dial in: +1-866-291-4...
..., Scientists at the U.S. Department of Energy,s L...rsity of California at Berkeley have created the w...n nanowire arrays, combining light sensors and ele...Their method can be used to reproduce numerous suc... made with specific chemical, electronic, and othe...
...VALENCIA, Calif., Aug. 4 MannKind Corporation,(Na... financial results on,Monday, August 11, 2008 at 4...t a conference call to discuss the,second quarter ...pany,developments at 5:00 p.m. EDT on Monday, Augu...ts Chairman and Chief Executive Officer, Alfred Ma...
Other Biology Technology:A first in integrated nanowire sensor circuitry 2A first in integrated nanowire sensor circuitry 3A first in integrated nanowire sensor circuitry 4MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008 2
(Date:11/4/2009)..., CHAPEL HILL Scientists at the University of...and the University of California, San Francisco ha... to predict new target diseases for existing drugs...thod that compares how similar the structures of a...ing partners -- known as ligands -- of disease tar...
(Date:11/3/2009)... , BOCA RATON, FL (November 4, 2009) For more th... the queen conch ( Strombus gigas ) have been unsu...roprietary seeding techniques to produce beaded (n...queen conch have been developed by scientists from...ographic Institute (HBOI). With less than two year...
(Date:11/3/2009)...AST LANSING, Mich. Obese women are as much as 28 ...successful pregnancy, according to research that e...onal award. , The findings by Barbara Luke, a re...partment of Obstetrics, Gynecology and Reproductiv...using assisted reproductive technology. , Luke,s...
Breaking Biology News(10 mins):Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 1Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 2Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 3Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 1Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 2Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 3Effective over the counter prostate cancer test kit likely in next few years 47790 1Effective over the counter prostate cancer test kit likely in next few years 47790 2
...PUBLICLY TRADED BROKERAGE TO UTILIZE TITANIUM,S ...OSE, Calif., Oct. 16 Titanium Group, Ltd,(OTC Bul...ity solutions,provider announced today that it has.... ("Haitong") (SHA: 600837). Titanium will install... newly renovated office in,Hong Kong. Haitong, lis...
...strial fishing operations take plenty of blame for...hing innocent bystanders such as dolphins, sharks,..."bycatch." , But new research shows that a small-... open boats--can kill as many critically endangere...fishing fleets in the North Pacific Ocean put toge...
...cur, in part, because of a problem in an intermitt...key chemical messenger in the brain, scientists ha...searchers found that the gene is turned on at incr...he prefrontal cortex, the part of the brain involv...making but that this normal increase may not occu...
Other Biology News:Titanium Group Announces Contract With Haitong Securities 2Titanium Group Announces Contract With Haitong Securities 3Titanium Group Announces Contract With Haitong Securities 4Small-scale fishing in Mexico rivals industrial fisheries in accidental turtle deaths 2Small-scale fishing in Mexico rivals industrial fisheries in accidental turtle deaths 3How schizophrenia develops: Major clues discovered 2
Custom Human Cytokine Antibody Array, Choose from hundreds of proteins. from Raybiotech, Inc.
Chicken Anti-VDAC3 Antibody, Unconjugated from ABR-Affinity BioReagents
Micro Slides from Santa Cruz Biotechnology, Inc.
MoDC Differentiation Kit from 3H Biomedical AB
Biology Products: